Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host.

Hdl Handle:
http://hdl.handle.net/10147/303304
Title:
Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host.
Authors:
Gallagher, D J; Vijai, J; Hamilton, R J; Ostrovnaya, I; Iyer, G; Garcia-Grossman, I R; Kim, P H; Przybylo, J A; Alanee, S; Riches, J C; Regazzi, A M; Milowsky, M I; Offit, K; Bajorin, D F
Affiliation:
Department of Medical Oncology and Cancer Genetics, Mater Hospital and St. James's Hospital, Dublin 7, Ireland Departments of.
Citation:
Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host. 2013, 24 (9):2414-21 Ann. Oncol.
Journal:
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Issue Date:
Sep-2013
URI:
http://hdl.handle.net/10147/303304
DOI:
10.1093/annonc/mdt225
PubMed ID:
23897706
Abstract:
Variations in urothelial carcinoma (UC) response to platinum chemotherapy are common and frequently attributed to genetic and epigenetic variations of somatic DNA. We hypothesized that variations in germline DNA may contribute to UC chemosensitivity.
Item Type:
Article
Language:
en
Keywords:
CANCER
Local subject classification:
CHEMOTHERAPY
ISSN:
1569-8041

Full metadata record

DC FieldValue Language
dc.contributor.authorGallagher, D Jen_GB
dc.contributor.authorVijai, Jen_GB
dc.contributor.authorHamilton, R Jen_GB
dc.contributor.authorOstrovnaya, Ien_GB
dc.contributor.authorIyer, Gen_GB
dc.contributor.authorGarcia-Grossman, I Ren_GB
dc.contributor.authorKim, P Hen_GB
dc.contributor.authorPrzybylo, J Aen_GB
dc.contributor.authorAlanee, Sen_GB
dc.contributor.authorRiches, J Cen_GB
dc.contributor.authorRegazzi, A Men_GB
dc.contributor.authorMilowsky, M Ien_GB
dc.contributor.authorOffit, Ken_GB
dc.contributor.authorBajorin, D Fen_GB
dc.date.accessioned2013-10-11T15:09:23Z-
dc.date.available2013-10-11T15:09:23Z-
dc.date.issued2013-09-
dc.identifier.citationGermline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host. 2013, 24 (9):2414-21 Ann. Oncol.en_GB
dc.identifier.issn1569-8041-
dc.identifier.pmid23897706-
dc.identifier.doi10.1093/annonc/mdt225-
dc.identifier.urihttp://hdl.handle.net/10147/303304-
dc.description.abstractVariations in urothelial carcinoma (UC) response to platinum chemotherapy are common and frequently attributed to genetic and epigenetic variations of somatic DNA. We hypothesized that variations in germline DNA may contribute to UC chemosensitivity.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Annals of oncology : official journal of the European Society for Medical Oncology / ESMOen_GB
dc.subjectCANCERen_GB
dc.subject.otherCHEMOTHERAPYen_GB
dc.titleGermline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology and Cancer Genetics, Mater Hospital and St. James's Hospital, Dublin 7, Ireland Departments of.en_GB
dc.identifier.journalAnnals of oncology : official journal of the European Society for Medical Oncology / ESMOen_GB
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.